Vitrafy Life Sciences Ltd. · ASX:VFY
Vitrafy Life Sciences — NWR Health Conference 2026
15 slides from Vitrafy Life Sciences's conference presentation, Mar 26, 2026
Slide 1: NWR Health Conference Presentation
For personal use only NWR Health Conference Presentation March 2026 1
Slide 2: Important Notice & Disclaimer
Important Notice & Disclaimer This presentation is provided by Vitrafy Life Sciences Limited (ACN 622 720 254) (the Company). Statements in this The distribution of this presentation may be restricted by law. Persons who come into possession of this presentation presentation are made only as at the
Slide 3: Important Notice & Disclaimer (cont.)
Important Notice & Disclaimer (cont.) Not financial product advice All figures in the presentation are Australian dollars ($ or A$) unless stated otherwise. A number of figures, amounts, Reliance should not be placed on the information or opinions contained in this presentation. This presentation is
Slide 4: What is cryopreservation?
What is cryopreservation? For personal use only The science of preserving biological materials at ultra-low temperatures that underpins many areas of the healthcare system. Our priority markets are: • Cell & gene therapies. • Blood products. • Animal and aquaculture reproduction.
Slide 5: Built for 1960s Science
Built for 1960s Science Cryopreservation is breaking under 21st-century demand For personal use only Isolated Technology: Stand-alone cryopreservation unit is the current gold standard. No intelligence or insight: Data capture and analytics to support GMP compliance and FDA approvals uncommon. Damag
Slide 6: Cryopreservation is broken.
Cryopreservation is broken. For personal use only • US blood supply has experienced repeated declared shortage events since 2020. • Scaling cryopreservation manufacturing is the cell & gene sector’s most cited hurdle. • 60% of cell and gene therapy manufacturers are running default freeze profiles t
Slide 7: Building a cryopreservation ecosystem
Vitrafy Life Sciences (ASX: VFY) is building a For personal use only cryopreservation ecosystem that digitises, optimises, and decentralises the preservation and transport of biological materials.
Slide 8: Vitrafy cryopreservation ecosystem delivers customer value at the solution level
Vitrafy cryopreservation ecosystem delivers customer value at the solution level. For personal use only • Connected: end-to-end ecosystem connection. • Intelligent: Data capture and analytics empowering intelligent decision making. Guardion Cryopreservation Freezer Unit LifeChain Software Orchestrat
Slide 9: Guardion Hardware
Guardion Hardware Legacy Hardware Vitrafy Guardion For personal use only ▼ Manual, operator dependent Controlled & tailored cryopreservation ▼ Limited intelligence Automated & Intelligence ▼ Limited throughput Continuous Throughput ▼ Slow and inconsistent freeze cycles (hours) Rapid processing times
Slide 10: LifeChain Software
LifeChain Software For personal use only Standardisation: Facilitates the standardisation of quality outcomes ensuring consistency LifeChain delivers across multiple sites. quality control across Auditability: Chain of the pre-clinical, clinical command functionality ensures and commercial supply wo
Slide 11: Preserving sample quality with consistency
By preserving sample For personal use only quality with consistency, the Vitrafy ecosystem unlocks better products and better care when it matters most.
Slide 12: One Solution, Multiple Go-to-Market Applications
One Solution, Multiple Go-to-Market Applications For personal use only Vitrafy’s Animal Reproduction Blood & Blood Products Cell & Gene Therapies cryopreservation ecosystem has Why broad applicability Global Scale Critical & growing need Rapid growth across biological Global Scale Needs solutions ma
Slide 13: Commercial Progress
Commercial Progress With clear pathway to commercial adoption across our target markets. For personal use only Clear strategic pillar for Animal Established US Second-generation Health Operations with Guardion freezer commercialisation experienced, in unit launched in with a global country the US. l
Slide 14: Outlook
Outlook • Expand and convert new & existing customer pipeline opportunities in Human Health; For personal use only • Successfully complete the phase II studies with the USAISR; • Commencing work under the agreement with IMV Technologies and scaling existing aquaculture clients; • Commencing and secu
Slide 15: Follow our progress
Follow our progress For personal use only linkedin.com/company/vitrafy-life-sciences vitrafy.com VFY.ASX